🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Status
Completed
Location
Centre pour le Developpement des Vaccins du Mali
Start Date
2022-03-24
Trial ID
NCT05093829
Treatments Being Tested
A phase 2/3 study to determine the efficacy, safety and immunogenicity of t...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-05-28
Trial ID
NCT04400838
Treatments Being Tested
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested
This study is to confirm non-inferiority of the three MenACWY vaccines (Men...
Status
Completed
Location
Children's Hospital Research Institute, University of Calgary
Start Date
2018-09-20
Trial ID
NCT03694405
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01767376
Treatments Being Tested
A previous cohort of 93 clinical trial participants received quadrivalent m...
Status
Completed
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02811120
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of mRN...
Status
Active Not Recruiting
Location
Matrix Clinical Research
Start Date
2023-02-15
Trial ID
NCT05743881
The purpose of this study is to assess the safety and reactogenicity of an ...
Status
Completed
Location
Barwon Health
Start Date
2019-01-21
Trial ID
NCT03606512
Treatments Being Tested